{"title":"Appraisal of Surelease Clear E-7–19040, an Ethylcellulose Aqueous Dispersion, as a Release Modifier for the Hydrophilic Core","authors":"Pramod Parshuramkar, Deepak Khobragade, Pranita Kashyap","doi":"10.1007/s12247-022-09693-3","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>This study evaluated the efficacy of ethylcellulose aqueous dispersion type B (surelease clear E-7–19040) in modifying the drug release from the hydrophilic cores. Because of its ideal physicochemical and biological properties for the controlled-release formulation, Pindolol was selected as the model drug.</p><h3>Methods</h3><p>The final modified-release drug product comprises the immediate-release loading dose and the controlled-release maintenance dose. The tablet formulation was designed to have a seal-coated hydrophilic core with 75% of the drug, followed by a controlled-release polymer coating, immediate-release drug coating with 25% of the drug, followed by a color film coating.</p><h3>Results</h3><p>The controlled-release polymer coating was the critical step to achieving the desired product characteristics. During the coating of aqueous polymer dispersions, the adjustment of the controlled-release polymer to the pore former ratio, the control of the manufacturing process parameters, and the curing conditions are vital to developing a robust and stable end product. The final drug product achieved a targeted drug release profile in the selected dissolution method without a dose-dumping effect in the presence of alcohol and was unaffected by the accelerated stability study condition.</p><h3>Conclusion</h3><p>The ethylcellulose aqueous dispersion type B is very effective in modulating the release of hydrophilic drug core for achieving a desired drug release profile as per the drug product’s quality target product profile and the material of choice for the organic solvent-free, eco-friendly, controlled-release polymer coating system.</p></div>","PeriodicalId":656,"journal":{"name":"Journal of Pharmaceutical Innovation","volume":"18 3","pages":"923 - 933"},"PeriodicalIF":2.7000,"publicationDate":"2022-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Innovation","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s12247-022-09693-3","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 1
Abstract
Purpose
This study evaluated the efficacy of ethylcellulose aqueous dispersion type B (surelease clear E-7–19040) in modifying the drug release from the hydrophilic cores. Because of its ideal physicochemical and biological properties for the controlled-release formulation, Pindolol was selected as the model drug.
Methods
The final modified-release drug product comprises the immediate-release loading dose and the controlled-release maintenance dose. The tablet formulation was designed to have a seal-coated hydrophilic core with 75% of the drug, followed by a controlled-release polymer coating, immediate-release drug coating with 25% of the drug, followed by a color film coating.
Results
The controlled-release polymer coating was the critical step to achieving the desired product characteristics. During the coating of aqueous polymer dispersions, the adjustment of the controlled-release polymer to the pore former ratio, the control of the manufacturing process parameters, and the curing conditions are vital to developing a robust and stable end product. The final drug product achieved a targeted drug release profile in the selected dissolution method without a dose-dumping effect in the presence of alcohol and was unaffected by the accelerated stability study condition.
Conclusion
The ethylcellulose aqueous dispersion type B is very effective in modulating the release of hydrophilic drug core for achieving a desired drug release profile as per the drug product’s quality target product profile and the material of choice for the organic solvent-free, eco-friendly, controlled-release polymer coating system.
期刊介绍:
The Journal of Pharmaceutical Innovation (JPI), is an international, multidisciplinary peer-reviewed scientific journal dedicated to publishing high quality papers emphasizing innovative research and applied technologies within the pharmaceutical and biotechnology industries. JPI''s goal is to be the premier communication vehicle for the critical body of knowledge that is needed for scientific evolution and technical innovation, from R&D to market. Topics will fall under the following categories:
Materials science,
Product design,
Process design, optimization, automation and control,
Facilities; Information management,
Regulatory policy and strategy,
Supply chain developments ,
Education and professional development,
Journal of Pharmaceutical Innovation publishes four issues a year.